Alphamab Oncology
HKEX:9966
Alphamab Oncology
Total Other Income
Alphamab Oncology
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Alphamab Oncology
HKEX:9966
|
Total Other Income
-¥984k
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Total Other Income
¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
440%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Total Other Income
-¥6.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Total Other Income
-¥29.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Total Other Income
¥249.8k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alphamab Oncology's Total Other Income?
Total Other Income
-984k
CNY
Based on the financial report for Dec 31, 2023, Alphamab Oncology's Total Other Income amounts to -984k CNY.
What is Alphamab Oncology's Total Other Income growth rate?
Total Other Income CAGR 3Y
-24%
Over the last year, the Total Other Income growth was 12%. The average annual Total Other Income growth rates for Alphamab Oncology have been -24% over the past three years .